Stayble Therapeutics AB (publ) (STO: STABL)
Sweden
· Delayed Price · Currency is SEK 0.410
+0.012 (3.02%)
Dec 23, 2024, 5:21 PM CET
Stayble Therapeutics AB Revenue
Stayble Therapeutics AB had revenue of 18.00K SEK in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to 376.00K, up 4,077.78% year-over-year.
Revenue (ttm)
376.00K
Revenue Growth
+4,077.78%
P/S Ratio
n/a
Revenue / Employee
188.00K
Employees
3
Market Cap
17.93M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca PLC | 519.35B |
| Swedish Orphan Biovitrum AB (publ) | 25.44B |
| Sectra AB (publ) | 3.14B |
| Getinge AB (publ) | 33.59B |
| Camurus AB (publ) | 1.69B |
| Vitrolife AB (publ) | 3.56B |
| Medicover AB (publ) | 22.60B |
| Bonesupport Holding AB (publ) | 814.46M |